Non-tuberculous mycobacterial infections should refer to non-tuberculous mycobacterial infections, which should be treated by actively seeking medical attention and selecting sensitive antibiotics after strain identification and drug sensitivity testing of the mycobacteria.
Non-tuberculous mycobacteria are mycobacteria other than Mycobacterium tuberculosis complex and Mycobacterium leprae, which can cause lymphadenitis, chronic lung disease, skin and soft tissue infections and systemic disseminated non-tuberculous mycobacteriosis.
Compared with Mycobacterium tuberculosis, Mycobacterium tuberculosis is less virulent and pathogenic than Mycobacterium tuberculosis, and is mostly an opportunistic pathogen.
If non-tuberculous mycobacterial infection is found, sensitive antibiotics should be selected for treatment after strain identification and drug sensitivity test of mycobacteria, commonly used drugs include clarithromycin, azithromycin, ethambutol, amikacin, ciprofloxacin, moxifloxacin, rifampicin and so on.
If non-tuberculous mycobacterial infection is found, it should be actively consulted and treated. The above drugs need to be used in a standardized manner under the guidance of a doctor to avoid adverse consequences.